Molecular diversity at the CYP2D6 locus in the Mediterranean region

被引:43
作者
Fuselli, S
Dupanloup, I
Frigato, E
Cruciani, F
Scozzari, R
Moral, P
Sistonen, J
Sajantila, A
Barbujani, G
机构
[1] Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy
[2] Univ Roma La Sapienza, Dept Genet & Mol Biol, I-00185 Rome, Italy
[3] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain
[4] Univ Helsinki, Dept Forens Med, Helsinki 00014, Finland
[5] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland
关键词
genetic diversity; single-nucleotide polymorphisms; SNaPshot genotyping; linkage disequilibrium; mutation; selection;
D O I
10.1038/sj.ejhg.5201243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the importance of cytochrome P450 in the metabolism of many drugs, several aspects of molecular variation at one of the main loci coding for it, CYP2D6, have never been analysed so far. Here we show that it is possible to rapidly and efficiently genotype the main European allelic variants at this locus by a SNaPshot method identifying chromosomal rearrangements and nine single-nucleotide polymorphisms. Haplotypes could be reconstructed from data on 494 chromosomes in six populations of the Mediterranean region. High levels of linkage disequilibrium were found within the chromosome region screened, suggesting that CYP2D6 may be part of a genomic recombination block, and hence that, aside from unequal crossingover that led to large chromosomal rearrangements, its haplotype diversity essentially originated through the accumulation of mutations. With the only, albeit statistically insignificant, exception of Syria, haplotype frequencies do not differ among the populations studied, despite the presence among them of three well-known genetic outliers, which could be the result of common selective pressures playing a role in shaping CYP2D6 variation over the area of Europe that we surveyed.
引用
收藏
页码:916 / 924
页数:9
相关论文
共 50 条
[1]   Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden [J].
Aklillu, E ;
Herrlin, K ;
Gustafsson, LL ;
Bertilsson, L ;
Ingelman-Sundberg, M .
PHARMACOGENETICS, 2002, 12 (05) :375-383
[2]  
Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441
[3]   Population-genetic basis of haplotype blocks in the 5q31 region [J].
Anderson, EC ;
Slatkin, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (01) :40-49
[4]   The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant -: Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations [J].
Bapiro, TE ;
Hasler, JA ;
Ridderström, M ;
Masimirembwa, CM .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (09) :1387-1398
[5]   ZONES OF SHARP GENETIC CHANGE IN EUROPE ARE ALSO LINGUISTIC BOUNDARIES [J].
BARBUJANI, G ;
SOKAL, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1816-1819
[6]   Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs [J].
Bertilsson, L ;
Dahl, ML ;
Dalén, P ;
Al-Shurbaji, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) :111-122
[7]   HUMAN MITOCHONDRIAL-DNA VARIATION AND THE ORIGIN OF BASQUES [J].
BERTRANPETIT, J ;
SALA, J ;
CALAFELL, F ;
UNDERHILL, PA ;
MORAL, P ;
COMAS, D .
ANNALS OF HUMAN GENETICS, 1995, 59 :63-81
[8]   CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants [J].
Bradford, LD .
PHARMACOGENOMICS, 2002, 3 (02) :229-243
[9]  
Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN
[10]   TCS: a computer program to estimate gene genealogies [J].
Clement, M ;
Posada, D ;
Crandall, KA .
MOLECULAR ECOLOGY, 2000, 9 (10) :1657-1659